Claritin brand licensed for fabrics
This article was originally published in The Tan Sheet
Executive SummaryMerck out-licenses its OTC allergy relief brand to London Luxury for a line of allergen barrier fabric products. Merck acquired the Claritin brand in its Schering-Plough merger in 2009 and called the licensing deal "an opportunity to extend our brand and reach consumers in new, innovative ways," according to a Sept. 13 press release. New Rochelle, N.Y.-based London Luxury introduced the Claritin bedding line, which protects against allergens such as dust mites and pet dander, to the trade this month but has yet to set a retail launch date. The companies did not disclose the value or duration of the exclusive licensing agreement
You may also be interested in...
ICER president Steve Pearson is ‘cautiously optimistic’ that net pricing for acute migraine treatments will align with benefits once discounts are factored in.
Almost 50 novel agents are already under review at FDA for potential 2020 approval. Candidates are notably diverse, with concentrations in established strongholds (oncology, neuroscience), popular programs (breakthrough), and powerhouse sponsors (keep an eye on Bristol-Myers Squibb right out of the gate).
CBER is starting the year with four novel gene and cell therapy applications under review and rolling submissions underway for more.